{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:49:10Z","timestamp":1762102150193,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:00:00Z","timestamp":1515110400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:00:00Z","timestamp":1515110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U10HD047892"],"award-info":[{"award-number":["U10HD047892"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000423"],"award-info":[{"award-number":["UL1TR000423"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00280-017-3511-6","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T04:09:54Z","timestamp":1515125394000},"page":"455-460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pharmacokinetics of dacarbazine (DTIC) in pregnancy"],"prefix":"10.1007","volume":"81","author":[{"given":"Ira","family":"Kantrowitz-Gordon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Hays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olumide","family":"Kayode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya R.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry G.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel M.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie L.","family":"Safgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew M.","family":"Ames","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Easterling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary F.","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"issue":"2","key":"3511_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejca.2005.10.014","volume":"42","author":"G Pentheroudakis","year":"2006","unstructured":"Pentheroudakis G, Pavlidis N (2006) Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 42(2):126\u2013140","journal-title":"Eur J Cancer"},{"issue":"1","key":"3511_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00277-004-0939-7","volume":"84","author":"A M\u00fcller","year":"2005","unstructured":"M\u00fcller A, Ihorst G, Mertelsmann R, Engelhardt M (2005) Epidemiology of non-Hodgkin\u2019s lymphoma (NHL): trends, geographic distribution and etiology. Ann Hematol 84(1):1\u201312","journal-title":"Ann Hematol"},{"issue":"9","key":"3511_CR3","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3324\/haematol.11097","volume":"92","author":"D Pereg","year":"2007","unstructured":"Pereg D, Koren G, Lishner M (2007) The treatment of Hodgkin\u2019s and non-Hodgkin\u2019s lymphoma in pregnancy. Haematologica 92(9):1230\u20131237","journal-title":"Haematologica"},{"issue":"3","key":"3511_CR4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/0002-9378(52)90071-9","volume":"63","author":"HL Stewart","year":"1952","unstructured":"Stewart HL, Monto RW (1952) Hodgkin\u2019s disease and pregnancy. Am J Obstet Gynecol 63(3):570\u2013578","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"3511_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0360-3016(92)90761-6","volume":"23","author":"SY Woo","year":"1992","unstructured":"Woo SY, Fuller LM, Cundiff JH, Bondy ML, Hagemeister FB, Mclaughlin P, Velasquez WS, Swan F, Alma Rodriguez M, Cabanillas F, Allen PK, Carpenter RJ (1992) Radiotherapy during pregnancy for clinical stages IA\u2013IIA Hodgkin\u2019s disease. Int J Radiat Oncol Biol Phys 23(2):407\u2013412","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"3511_CR6","first-page":"2192","volume":"5","author":"JM Reid","year":"1999","unstructured":"Reid JM, Kuffel MJ, Miller JK, Rios R, Ames MM (1999) Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1. Clin Cancer Res 5(8):2192\u20132197","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3511_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00265388","volume":"9","author":"H Breithaupt","year":"1982","unstructured":"Breithaupt H, Dammann A, Aigner K (1982) Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules. Cancer Chemother Pharmacol 9(2):103\u2013109","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"3511_CR8","first-page":"149","volume":"60","author":"TL Loo","year":"1976","unstructured":"Loo TL, Housholder GE, Gerulath AH, Saunders PH, Farquhar D (1976) Mechanism of action and pharmacology studies with DTIC (NSC-45388). Cancer Treat Rep 60(2):149\u2013152","journal-title":"Cancer Treat Rep"},{"issue":"8","key":"3511_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/bms.1200100808","volume":"10","author":"P Farina","year":"1983","unstructured":"Farina P, Benfenati E, Reginato R, Torti L, D\u2019Incalci M, Threadgill MD, Gescher A (1983) Metabolism of the anticancer agent 1-(4-acetylphenyl)-3,3-dimethyltriazene. Biomed Mass Spectrom 10(8):485\u2013488","journal-title":"Biomed Mass Spectrom"},{"issue":"6","key":"3511_CR10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1128\/AAC.27.6.977","volume":"27","author":"D Fiore","year":"1985","unstructured":"Fiore D, Jackson AJ, Didolkar MS, Dandu VR (1985) Simultaneous determination of dacarbazine, its photolytic degradation product, 2-azahypoxanthine, and the metabolite 5-aminoimidazole-4-carboxamide in plasma and urine by high-pressure liquid chromatography. Antimicrob Agents Chemother 27(6):977\u2013979","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"3511_CR11","first-page":"2448","volume":"28","author":"TL Loo","year":"1968","unstructured":"Loo TL, Luce JK, Jardine JH, Frei E (1968) Pharmacologic studies of the antitumor agent 5-(dimethyltriazeno)imidazole-4-carboxamide. Cancer Res 28(12):2448\u20132453","journal-title":"Cancer Res"},{"issue":"1","key":"3511_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0378-4347(00)00586-7","volume":"754","author":"SL Safgren","year":"2001","unstructured":"Safgren SL, Reid JM, Rios R, Ames MM (2001) Validated high-performance liquid chromatographic assay for simultaneous determination of dacarbazine and the plasma metabolites 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide and 5-(3-methyl-1-triazeno)imidazole-4-carboxamide. J Chromatogr B Biomed Sci Appl 754(1):91\u201396","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"5","key":"3511_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/clpt.1992.171","volume":"52","author":"MF Hebert","year":"1992","unstructured":"Hebert MF, Roberts JP, Prueksaritanont T, Benet LZ (1992) Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol Ther 52(5):453\u2013457","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"3511_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/0091270004269704","volume":"45","author":"MF Hebert","year":"2005","unstructured":"Hebert MF, Carr DB, Anderson GD, Blough D, Green GE, Brateng DA, Kantor E, Benedetti TJ, Easterling TR (2005) Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum. J Clin Pharmacol 45(1):25\u201333","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"3511_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.6004\/jnccn.2012.0061","volume":"10","author":"RT Hoppe","year":"2012","unstructured":"Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Winter JN, Yahalom J, Sundar H (2012) Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines. J Natl Compr Cancer Netw 10(5):589\u2013597","journal-title":"J Natl Compr Cancer Netw"},{"key":"3511_CR16","first-page":"CD007110","volume":"2","author":"C Herbst","year":"2011","unstructured":"Herbst C, Rehan FA, Skoetz N, Bohlius J, Brillant C, Schulz H, Monsef I, Specht L, Engert A (2011) Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma. Cochrane Database Syst Rev 2:CD007110","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"3511_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11899-013-0163-4","volume":"8","author":"V Bachanova","year":"2013","unstructured":"Bachanova V, Connors JM (2013) Hodgkin lymphoma in pregnancy. Curr Hematol Malig Rep 8(3):211\u2013217","journal-title":"Curr Hematol Malig Rep"},{"issue":"4","key":"3511_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/j.1447-0756.2010.01249.x","volume":"36","author":"D Sagan","year":"2010","unstructured":"Sagan D, Semczuk A, Lampka E (2010) Combination chemotherapy for Hodgkin\u2019s lymphoma during pregnancy: Favorable outcome for mother and child. J Obstet Gynaecol Res 36(4):882\u2013886","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"3511_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00280-014-2406-z","volume":"73","author":"RJ Ryu","year":"2014","unstructured":"Ryu RJ, Eyal S, Kaplan HG, Akbarzadeh A, Hays K, Puhl K, Easterling TR, Berg SL, Scorsone KA, Feldman EM, Umans JG, Miodovnik M, Hebert MF (2014) Pharmacokinetics of doxorubicin in pregnant women. Cancer Chemother Pharmacol 73(4):789\u2013797","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"3511_CR20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ajog.2004.08.030","volume":"192","author":"TS Tracy","year":"2005","unstructured":"Tracy TS, Venkataramanan R, Glover DD, Caritis SN (2005) Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol 192(2):633\u2013639","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"3511_CR21","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1365-2125.2012.04402.x","volume":"75","author":"A Kulo","year":"2013","unstructured":"Kulo A, Peeters MY, Allegaert K, Smits A, Hoon J, Verbesselt R, Lewi L, Velde M, Knibbe CAJ (2013) Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum. Br J Clin Pharmacol 75(3):850\u2013860","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"3511_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1471-0528.1980.tb04501.x","volume":"87","author":"JM Davison","year":"1980","unstructured":"Davison JM, Dunlop W, Ezimokhai M (1980) 24-hour creatinine clearance during the third trimester of normal pregnancy. Br J Obstet Gynaecol 87(2):106\u2013109","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"3511_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1471-0528.1981.tb00930.x","volume":"88","author":"JM Davison","year":"1981","unstructured":"Davison JM, Noble MC (1981) Serial changes in 24 h creatinine clearance during normal menstrual cycles and the first trimester of pregnancy. Br J Obstet Gynaecol 88(1):10\u201317","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"3511_CR24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s11095-007-9413-2","volume":"25","author":"T Iwamoto","year":"2007","unstructured":"Iwamoto T, Hiraku Y, Okuda M, Kawanishi S (2007) Mechanism of UVA-dependent DNA damage induced by an antitumor drug dacarbazine in relation to its photogenotoxicity. Pharm Res 25(3):598\u2013604","journal-title":"Pharm Res"},{"issue":"8","key":"3511_CR25","first-page":"2827","volume":"36","author":"DD Beal","year":"1976","unstructured":"Beal DD, Skibba JL, Whitnable KK, Bryan GT (1976) Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells. Can Res 36(8):2827\u20132831","journal-title":"Can Res"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-017-3511-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3511-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3511-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T11:31:19Z","timestamp":1589628679000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-017-3511-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3511"],"URL":"https:\/\/doi.org\/10.1007\/s00280-017-3511-6","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2018,1,5]]},"assertion":[{"value":"6 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Hebert received a research grant from the Eunice Kennedy Shriver National Institute of Child Health (Grant Number U10HD047892) and the study was conducted in the University of Washington Clinical Research Unit which is supported by a grant from the National Institutes of Health, National Center for Advancing Translational Sciences through the Clinical and Translational Science Awards Program (CTSA) (Grant Number UL1TR000423).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}